Retinal vessel analysis in hypercholesterolemic patients before and after LDL apheresis

Atherosclerosis Supplements

Volumn 10, Issue 5, 2009, Pages 39-43

  Reimann, Manja ^a   Prieur, Silke ^a   Lippold, Birgit ^a   Bornstein, Stefan R ^a   Reichmann, Heinz ^a   Julius, Ulrich ^a   Ziemssen, Tjalf ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Endothelial function; LDL apheresis; Retinal vessel analysis; Venular caliber

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPICAMIDE;

ADULT; APHERESIS; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; EYE EXAMINATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MICROCIRCULATION; PHOTOSTIMULATION; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINAL BLOOD VESSEL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION; VENULE;

ADULT; AGED; ARTERIOLES; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HOMEOSTASIS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PHOTIC STIMULATION; RETINAL VESSELS; TREATMENT OUTCOME; TRIGLYCERIDES; VASODILATION; VENULES;

EID: 72649096026     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(09)71808-2     Document Type: Article

References (30)

1. Julius U., Frind A., Tselmin S., Kopprasch S., Poberschin I., and Siegert G. Com parison of different LDL apheresis methods. Expert Rev Cardiovasc Ther 6 (2008) 629-639
2. Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., and Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95 (1997) 76-82
3. Kwa V.I., van der Sande J.J., Stam J., Tijmes N., and Vrooland J.L. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 59 (2002) 1536-1540
4. Nguyen T.T., and Wong T.Y. Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17 (2006) 262-268
5. Tedeschi-Reiner E., Strozzi M., Skoric B., and Reiner Z. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol 96 (2005) 1107-1109
6. Paz-Filho G.J., Andrews D., Esposito K., Erol H.K., Delibasi T., Wong M.L., and Licinio J. Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects. Horm Metab Res 41 (2009) 164-167
7. Rothe U., Muller G., Tselmin S., Odenbach C., Scheuch K., Koch R., Bergmann S., Walter M., Bergmann A., Bornstein S.R., and Schwarz P. Prevalence for the cluster of risk factors of the metabolic vascular syndrome in a working population in Germany. Horm Metab Res 41 (2009) 168-170
8. Schwarz P., Bornstein S.R., and Hanefeld M. The future of the metabolic syndrome. Horm metab Res 41 (2009) 73-74
9. Liew G., Wang J.J., Mitchell P., and Wong T.Y. Retinal vascular imaging: A new tool in microvascular disease research. Circ Cardiovasc Imaging 1 (2008) 156-161
10. Stolk R.P., Vingerling J.R., Cruickshank J.K., et al. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Contemp Clin Trials 28 (2007) 6-17
11. Nagel E., Vilser W., Fink A., and Riemer T. [Static vessel analysis in nonmydriatic and mydriatic images]. Klin Monatsbl Augenheilkd 224 (2007) 411-416
12. Parr J.C., and Spears G.F. General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery. Am J Ophthalmol 77 (1974) 472-477
13. Blum M., Bachmann K., Wintzer D., Riemer T., Vilser W., and Strobel J. Noninvasive measurement of the Bayliss effect in retinal auto- regulation. Graefes Arch Clin Exp Ophthalmol 237 (1999) 296-300
14. Polak K., Dorner G., Kiss B., et al. Evaluation of the Zeiss retinal vessel analyser. Br J Ophthalmol 84 (2000) 1285-1290
15. Igarashi K., Tsuji M., Nishimura M., and Horimoto M. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia. J Clin Apher 19 (2004) 11-16
16. Jaeger B.R., Bengel F.M., Odaka K., et al. Changes in myocardial vaso- reactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography. J Heart Lung Transplant 24 (2005) 2022-2030
17. Kobayashi K., Yamashita K., Tasaki H., et al. Evaluation of improved coronary flow velocity reserve using transthoracic Doppler echo- cardiography after single LDL apheresis. Ther Apher Dial 8 (2004) 383-389
18. Mellwig K.P., van Buuren F., Schmidt H.K., Wielepp P., Burchert W., and Horstkotte D. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment. Ther Apher Dial 10 (2006) 510-517
19. Dorner G.T., Garhofer G., Kiss B., et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 285 (2003) H631-H636
20. Wang Y., Blessing F., Walli A.K., Uberfuhr P., Fraunberger P., and Seidel D. Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins-reduction of circulating proinflammatory and procoagulatory markers. Atherosclerosis 175 (2004) 145-150
21. Ramunni A., Ranieri G., Giancipoli G., et al. Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers?. Blood Purif 24 (2006) 405-412
22. Kojima S., Shida M., and Yokoyama H. Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis. Ther Apher Dial 7 (2003) 431-434
23. Stojakovic T., Scharnagl H., Marz W., Winkelmann B.R., Boehm B.O., and Schmut O. Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion. Clin Chim Acta 382 (2007) 77-81
24. Stokes K.Y., Calahan L., Hamric C.M., Russell J.M., and Granger D.N. CD40/ CD40L contributes to hypercholesterolemia-induced micro vascular inflammation. Am J Physiol Heart Circ Physiol 296 (2009) H689-H697
25. Wong T.Y., and Mitchell P. The eye in hypertension. Lancet 369 (2007) 425-435
26. Liew G., Sharrett A.R., Wang J.J., et al. Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study. Arch Ophthalmol 126 (2008) 1404-1410
27. Sun C., Wang J.J., Mackey D.A., and Wong T.Y. Retinal vascular caliber: sys temic, environmental, and genetic associations. Surv Ophthalmol 54 (2009) 74-95
28. Wong T.Y., Klein R., Klein B.E., Tielsch J.M., Hubbard L., and Nieto F.J. Retinal microvascular abnormalities and their relationship with hyper tension, cardiovascular disease, and mortality. Surv Ophthalmol 46 (2001) 59-80
29. Klein R., Sharrett A.R., Klein B.E., et al. Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 20 (2000) 1644-1650
30. Wong T.Y., Kamineni A., Klein R., et al. Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med 166 (2006) 2388-2394